Alnylam Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ALNY Alnylam Pharmaceuticals Inc
VGI Virtus Global Multi-Sector Income Fund
VDE Vanguard Energy Index Fund ETF Shares
VCV Invesco California Value Municipal Income Trust
VCSH Vanguard Short-Term Corporate Bond Index Fund ETF Shares
VBR Vanguard Small-Cap Value Index Fund ETF Shares
V Visa Inc
UPS United Parcel Service Inc
UNM Unum Group
UNH UnitedHealth Group Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgalactosamine (GalNAc)-conjugate platform for delivery of small interfering RNAs (siRNAs). Its pipeline of investigational RNAi therapeutics focuses on three Strategic Therapeutic Areas (STArs): Genetic Medicines, with multiple product candidates for the treatment of rare diseases; Cardio-Metabolic Diseases, with product candidates directed toward genetically validated, liver-expressed disease targets for unmet needs in cardiovascular and metabolic diseases, and Hepatic Infectious Diseases, with product candidates designed to address the global health challenges of hepatic infectious diseases, beginning with hepatitis B and hepatitis D viral infections.

Closing Price
$148.77
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,272,986
0
  • Prev Close
    148.77
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    4:00p ET 07/01/20
  • Last (size)
    12
  • 52-Wk Range
    69.11 - 158.37
    LowHigh
  • (08/06/19 - 06/26/20)
    6.06%
  • 45.1%
  • Market Cap
    17.1B
  • Shares Outstanding
    114.8M
  • -8.03
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.8
  • 95.41
  • (% of float 06/15/20)
    5.29

Latest News

June 30, 2020
9:00 am ET
BusinessWire
June 18, 2020
7:00 am ET
BusinessWire
June 17, 2020
4:00 pm ET
BusinessWire
June 10, 2020
5:07 pm ET
BusinessWire
June 07, 2020
7:15 am ET
BusinessWire
June 02, 2020
8:00 am ET
BusinessWire
June 01, 2020
7:00 am ET
BusinessWire
May 26, 2020
4:00 pm ET
BusinessWire
7:00 am ET
BusinessWire
May 22, 2020
12:30 pm ET
BusinessWire
May 16, 2020
12:02 pm ET
MarketWatch
May 12, 2020
4:01 pm ET
Globe Newswire
May 11, 2020
8:00 am ET
BusinessWire
May 07, 2020
8:13 am ET
MarketWatch
May 06, 2020
8:00 am ET
BusinessWire
May 04, 2020
7:30 am ET
BusinessWire
April 23, 2020
8:00 am ET
BusinessWire
April 15, 2020
4:01 pm ET
Globe Newswire
April 14, 2020
7:00 am ET
BusinessWire
April 13, 2020
4:00 pm ET
BusinessWire
7:35 am ET
MarketWatch
7:31 am ET
MarketWatch
7:30 am ET
BusinessWire
April 07, 2020
7:00 am ET
BusinessWire
April 06, 2020
7:00 am ET
BusinessWire
March 04, 2020
2:01 pm ET
MarketWatch
7:27 am ET
MarketWatch
7:05 am ET
MarketWatch
February 11, 2020
9:07 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.